Human papillomavirus vaccination - UpToDate
uptodate.com · 428 words · saved by 1 readers
{{configCtrl2.info.metaDescription}}
Human papillomavirus vaccination INTRODUCTION Human papillomavirus (HPV) is a sexually transmitted pathogen that causes anogenital and oropharyngeal disease in males and females. Persistent viral infection with high-risk HPV genotypes causes virtually all cancers of the cervix. The high-risk HPV genotypes (or "types") 16 and 18 cause approximately 70 percent of all cervical cancers worldwide, and types 31, 33, 45, 52, and 58 cause an additional 20 percent, with nonvaccine high-risk types 35, 39, 51, 56, 59, and 68 causing almost all of the remaining 10 percent. HPV types 16 and 18 also…
related reading
- Human Papillomavirus Vaccine Efficacy and Effectiveness against Cancer - PubMedpubmed.ncbi.nlm.nih.gov
- Real-World Effectiveness of Human Papillomavirus Vaccination Against Cervical Cancer - PMCncbi.nlm.nih.gov
- HPV and Cancer - NCIcancer.gov
- RETRACTED ARTICLE: Molecular mechanisms in progression of HPV-associated cervical carcinogenesis | Journal of Biomedical Science | Springer Nature Linkjbiomedsci.biomedcentral.com
- HPV vaccine cutting cervical cancer by nearly 90%bbc.com
- 人類乳突瘤病毒(Human papilloma virus; HPV) 與子宮頸癌的關係::台灣癌症基金會canceraway.org.tw
- Frontiers | Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapyfrontiersin.org
- The golden age of vaccine development - Works in Progress Magazineworksinprogress.co
- Medical breakthroughs in 2025 - by Saloni Dattaniscientificdiscovery.dev
- HIV-related lymphomas: Primary central nervous system lymphomauptodate.com
- radvacradvac.org
- Frontiers | Epstein–Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Updatefrontiersin.org